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We read with great interest the paper by Porcheddu 
et al. [1], who showed the similarity (2.3%) in Case 
Fatality Ratio (CFR) of COVID-19 in Italy and China. 
However, we believe that both the calculation and 
comparison of the two mentioned CFRs are deeply 
biased. Indeed, the formula used by authors for 
calculating the CFR, i.e. the total number of known 
deaths divided by the total number of confirmed cases, 
expressed as a percent, is reliable once an epidemic has 
ended, but it does not represent the true case fatality rate 
while the epidemic is still ongoing [2]. Moreover, 
authors compared data drawn by two time intervals with 
different lengths, i.e. 21-28 February in Italy (8 days), 
and 19 January-11 February in China (24 days). We 
agree with Battegay et al. [3], that a precise estimate of 
the case fatality rate is impossible at present, and, for 
this reason, we should be cautious when research 
findings and strategies are taken on the basis of these 
estimates. To date, there is lack of coordination and 
resources for an integrated and homogeneous 
epidemiological surveillance worldwide, which does 
not allow comparisons to be made between countries. 
The degree of underreporting COVID-19 cases varies 
over time as well as between countries. Thus, the CFR 
may be overestimated, when mild or asymptomatic 
cases are unrecognized, or may be underestimated, 
when unclear deaths are not attributed to the SARS-
CoV-2 [3]. In confirmation of this, while the 2003 
SARS epidemic was still going, the World Health 
Organization (WHO) reported a CFR of 4%, that 
became equal to 9.6% at the end of the epidemics. 
However, as suggested by Worldometer [2], a reference 
website that provides real-time world statistics, at the 
present time, the well-known formula proposed by 
Ghani et al. [4] for calculating the CFR of the 2003 
SARS epidemics could be applicable to the current 
SARS-CoV 2 epidemics as well, as it is needed to 
divide cases and deaths belonging to the same group of 
patients. In other words, it would be more accurate to 
calculate the ratio between the deaths at time T1 (e.g. 
day 15) and confirmed cases at time T0 (e.g. day 9), 
where T0 precedes T1 (e.g. 6 days) and depends on the 
incubation period (“the time between exposure to the 
virus and the onset of symptoms”) of the infection, i.e. 
that for SARS-CoV2 is ranged from 2 to 7 days, with a 
mean incubation period of 6.4 days. [5]. Therefore, the 
formu la modified would be as follows: 
 
CFR =  deaths at 𝑻𝑻𝟏𝟏/(cases at 𝑻𝑻𝟎𝟎 −  𝑇𝑇) 
 
Where T is the average time period from case 
confirmation to death. 
An alternative and simple method proposed by 
Ghani et al. [4] would follow the formula: CFR =
 deaths / (deaths +  recovered). 
In any case, whatever the calculation and the 
formula used, if we want to compare CFR between 
countries, the most important requirement is the 
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